Professional Documents
Culture Documents
SYNOPSIS OF DISSERTATION
Submitted by
DR. JIMUT BAHAN MURMU, MBBS
1st YEAR POST GRADUATE TRAINEE,
DEPARTMENT OF RADIODIAGNOSIS
GUIDE
CO-GUIDE
I hereby declare that, I, Dr. Jimut Bahan Murmu, Post Graduate Trainee ( Session 2018-2021)
in the department of Radio-Diagnosis, NilratanSircar Medical College and Hospital, Kolkata,
am doing the study entitled “Correlation of Ultrasonography and Magnetic resonance
cholangiopancreatography in different types of Choledochal Cysts” – a Hospital base
cross sectional study under the guidance and close supervision of Prof.( Dr.) Swadha Priya
Basu, Professor & HOD, Department of Radio-Diagnosis, Nilratan Sircar Medical College &
Hospital, Kolkata & Prof. Dr. Nisith Chandra Karmakar, Professor, Department of General
Surgery, Nilratan Sircar Medical College & Hospital, Kolkata, solely for the purpose of my
thesis as a part of my M.D. course. I shall be liable to bring to notice of the Ethics Committee
the developments regarding this study including any adverse outcome. The protocol will be in
parity with the present standards maintained in this hospital. The investigations and treatment
will be done in Govt. hospital set-up and those which will not be available in Govt. setup will
be done from outside.
4. Study Population: The study will be of hospital base cross sectional study comprising of thirty patients
who will be referred for Ultrasonography and Magnetic resonance cholangiopancreatography to the
department of Radiodiagnosis, Nilratan Sircar Medical College, Kolkata, with clinical suspicion of
Choledochal Cysts lesions and incidentally found Choledochal Cysts lesions on patient’s
Ultrasonography and Magnetic resonance cholangiopancreatography done for other reasons during
January 2019 to June 2020.
Exclusion Criteria: Critically ill and Moribund patients.
5. Sample Size: 30 patients(minimum)
6. Sample Design: Randomized
7. Data collection & interpretation: A proforma will be made. The relevant clinical findings are filled up
from case records and investigations are noted for interpretation.
g) Statistical analysis plan: Data analysis will be done using rate, ratios, percentages etc by using
proper statistical method.
h) Justification and Use of the Results: From this study expected outcomes will be –
i) Percentage of different types of Choledochal Cysts in this region.
ii) Major clinical Presentation.
iii) Age and Sex wise distribution.
iv) Classification of different varieties Cysts with sonographic and Magnetic resonance
cholangiopancreatographic findings according to its location.
v) Ultrasonography and Magnetic resonance cholangiopancreatography are complementary
imaging modalities in the evaluation of suspected case of Choledochal Cysts. Thus, in all the cases both
these modalities have their own importance in diagnosing and classifying different types of Choledochal
Cysts and should be used in combination for accurate diagnosis and treatment
2. TITLE
3 BACKGROUND
A) Justification and relevance of the proposed research work:
Choledochal Cysts are most commonly present in childhood and about 25% patients present in
adulthood4. The classic triad of symptoms, which includes pain abdomen, palpable abdominal
mass, and jaundice, is seen in less than 20% of cases. An 85% of children have at least 2 features
of classic triad, whereas only 25% of adults present with at least 2 features of the classic triad9.
Although benign, Choledochal Cyst can be associated with serious complications including
malignant transformation, cholangitis, pancreatitis, and cholelithiasis4,5.
Ultrasound is the most frequently used imaging modality for its low cost, accessibility, and has
been shown to be reliable and cost effective for investigation of Choledochal Cyst And it is first
line of investigation at the current time10,15.
A CBD measuring greater than the normal in comparison to age may be the possibilities of
cystic dilatation of the biliary tree or obstructive biliary lithiasis. Additionally, a right upper
quadrant cyst separate from the gallbladder is suggestive of Choledochal Cyst disease.
Choledochal cyst diagnosis is further supported by the presence of a direct communication
between the biliary tree and the cystic duct. These criteria allow for the differentiation of
Choledochal Cysts disease and other right upper quadrant cystic entities, such as pancreatic
pseudocyst, renal cyst, and hepatic cysts. Thickening and irregularity of the Choledochal Cysts
wall suggests malignancy10,15.
However, ultrasound fails to determine the cause of a dilated CBD in one-third of patients.
Moreover, it is unable to accurately identify APBDU (anomalous pancreaticobiliary duct
union)10,15.
Magnetic resonance cholangiopancreatography is noninvasive and does not require irradiation
or oral or intravenous contrast. Modern MRCP technology has removed the need for exaggerated
breath holding techniques, increasing its utility and accuracy. The MRCP is highly sensitive (90%
-100%) and specific (90% to 100%) in Choledochal Cyst diagnosis and classification. Moreover,
it reliably identifies APBDU (anomalous pancreaticobiliary duct union) as well as
cholangiocarcinoma and choledocholithiasis with concurrent Choledochal Cyst. Although MRCP
is associated with relatively lower cost and decreased morbidity, but it is limited in its ability to
detect minor ductal abnormalities or small choledochoceles12. The clinical classification, which
describes different types and subtypes, was revised in 1977 by Todani and colleagues. The most
common cystic dilatation is type I with diffuse or segmental fusiform dilatation of the common
bile duct. This type accounts for 50 to 85% of cases. Type I cysts should be considered in the
differential diagnosis of any patient with ductal dilatation1.
However, the recent experience of the different authors suggested that the disease currently is
recognized more commonly in adults5,9. Adult patients most commonly had abdominal pain and
were thought to have pancreatitis (23%) or acute biliary tract symptoms, prompting
cholecystectomy (50%). The type of choledochal cyst seen in children and adults was similar; the
fusiform extrahepatic (Type I) was most common (50%), and the combined intrahepatic and
extrahepatic (Type IVA) was the next most prominent (33%). Treatment consisted of excision of
the cyst and biliary reconstruction with a hepaticojejunostomy9.
B) Introduction:
Choledochal cysts are rare congenital anomalies in which cystic dilatations of the biliary
tree can involve extrahepatic biliary radicles, the intrahepatic radicles, or both. Choledochal
cysts are principally diagnosed by disproportionate dilatation of the biliary radicles. In
addition, choledochal cysts are believed to arise from the anomalous union of the common
bile duct and pancreatic duct outside the duodenal wall which is also proximal to the
sphincter of the Oddi mechanism14. The various types of choledochal cysts have been
classified on the basis of these anomalous unions (Komi classification) and their anatomical
locations (Todani classification)1,16.
The Todani classification of bile duct cysts divides choledochal cysts into five groups.
Type I: Fusiform dilation of the extrahepatic bile duct, account for 50-80% of all bile duct
cysts.
Type II: Bile duct diverticulum, Saccular outpouchings, 2% of all bile duct cysts.
Type III: Choledochocele, protrusion of a focally dilated, intramural segment of the distal
CBD into the duodenum.1.4-4.5% of all bile duct cysts.
Type IV: Multiple communicating intra and extrahepatic duct cysts, 15-35% of all bile duct
cysts.
This study describes the various imaging features of a choledochal cyst according to the
various types of anomalous unions of the pancreaticobiliary duct according to Komi's
classification and anatomic location according to Todani's classification
4. Review of literature:
Initial classification by Alonso-Lej and colleagues in 1959 described 3 types of choledochal
cysts, type I–III.
Later Todani and colleagues in 1977 modified it by adding type IV and V. Modified Todani
and colleague’s classification is most commonly used by surgeons. Type I choledochal cysts
make up about 50%–80% of all choledochal cysts, type II 2%, type III 1.4%–4.5%, type IV
15%–35%, and type V 20%.
Ziegler and colleagues in their analysis of comparing choledochoceles to Todani types I, II,
IV, and V, with respect to age, sex, complications, and management concluded that
classification of choledochal cysts should not include choledochoceles.
Lilly and colleagues described an entity called “forme fruste” choledochal cysts, where the
patients present with typical symptoms of choledochal cysts and are associated with abnormal
pancreaticobiliary duct junction (APBDJ) but without dilation of biliary ducts. Sarin and
colleagues believe this to be included under the spectrum of choledochal cysts.
Kaneyama and colleagues reported 4 cases of type II diverticulum arising from type IC
choledochal cysts, which they termed as mixed type I and II choledochal cysts. The incidence
was 1.1% in their series of 356 cases. Four cases have also been reported of diverticular cysts
of the cystic duct, which the authors suggested might be another subtype. The question arises,
however, whether this is just a variant type-II cyst.
Four cases of diverticular cysts of cystic duct have been reported by Loke and colleagues,
which might be another variant of choledochal cysts.
Visser and colleagues in their case series experienced all types of type I choledochal cysts
had some element of intrahepatic dilation making them to contend type I and IVA cysts are
variation of same disease and the degree of intrahepatic dilation defining one type versus the
other was arbitrary.
P A Lipsett have done a Retrospective Study with forty-two patients (11 children, 32 adults)
with choledochal cyst disease which were treated primarily between 1976 and 1993. One
child but no adults had the classic triad of jaundice, abdominal mass, and pain abdomen.
Children were more likely to have two of the three signs or symptoms (82% vs. 25%; p = <
0.05). Adult patients most commonly had abdominal pain and were thought to have
pancreatitis (23%) or acute biliary tract symptoms, prompting cholecystectomy (50%). The
type of choledochal cyst seen in children and adults was similar; the fusiform extrahepatic
(Type I) was most common (50%), and the combined intrahepatic and extrahepatic (Type
IVA) was the next most prominent (33%). Gallbladder or cholangiocarcinoma was identified
in three adults (9.7%).
5.OBJECTIVES
General:
➢ To evaluate and correlate the findings of Ultrasonography and Magnetic resonance
cholangiopancreatography in diagnosis of different types of Choledochal Cysts.
Specific
➢ To evaluate and correlate the accuracy of Ultrasonography and Magnetic resonance
cholangiopancreatography in diagnosis of different types of Choledochal Cysts.
➢ To study the effectiveness of Ultrasonography and Magnetic resonance
cholangiopancreatography as a prime diagnostic modality for patients with clinical
features of Choledochal Cysts.
➢ To assess the limitation of Ultrasonography and Magnetic resonance
cholangiopancreatography in diagnosis of different types of Choledochal Cysts.
7. Data collection & interpretation: A proforma will be made. The relevant clinical
findings are filled up from case records and investigations are noted. Parameters to be
studied:
A. Clinical –
History –
i) Examination of Abdomen
B. INVESTIGATIONS –
c) Pancreas-
- Size, shape, and associated mass lesion
- Echogenicity- Hypoechoic/Hyperechoic/Isoechoic/Anechoic,
- Uniformity- Homogeneous/Heterogeneous
- Calcification/Shadowing-Present/absent
- Guidance for further interventional procedure – FNAC/Biopsy
d) Any associated important findings– Enlarged Retroperitoneal/Peri-pancreatic lymph
node/Retroperitoneal/pancreatic mass etc.
8. STUDY TOOLS:
9.WORK PLAN:
We are going to do hospital base cross sectional study comprising of thirty patients
who will be referred for Ultrasonography and Magneti resonance cholangiopancreatography
to the department of Radiodiagnosis, Nilratan Sircar Medical College, Kolkata, with clinical
suspicion of Choledochal Cysts lesions and incidentally found Choledochal Cysts lesions on
patient’s Ultrasonography and Magnetic resonance cholangiopancreatography done for
other reasons during January 2019 to June 2020. First, we will clinically identify suspected
study cases. Then we shall subject the study cases for radiological investigation at
department of Radiodiagnosis Nilratan Sircar Medical College & Hospital, Kolkata.
At first, Consent forms are duly signed by the patient (parents in case of Minor)
Data will be compared and analysed with appropriate statistical tests to determine
significance level and power of study. Descriptive statistical analysis would be carried out in
the present study.
Case No. :
1. Patient Particulars –
Name:
Age:
Sex:
Religion:
Address:
2. Clinical History –
i. Pain - Present/Absent
i. Tenderness – Present/Absent
4. Systemic Examination –
❖ Examination of Abdomen-
5. Investigations –
> TC, DC
> ESR
> Fasting Blood Sugar
> Post prandial blood sugar
> Liver function test
> Serum amylase and lipase
> Serum urea and creatinine
> Coagulation profile
> Virology marker
> Estimation of CA-19.9
You are welcome to the Department of Radio-Diagnosis, Nilratan Sircar Medical College &
Hospital, Kolkata. The research we are doing is “Correlation Ultrasonography and Magnetic
resonance cholangiopancreatography (MRCP) in different types of Choledochal Cysts”.
Through this research work we are going to assess the relative frequency of occurrence of
the different types of Choledochal Cysts and evaluate the Sensitivity and Specificity of
Ultrasonography and Magnetic resonance cholangiopancreatography (MRCP) in this disease.
The reason why we included you in this study is that you are suffering from jaundice/ and
upper abdominal mass /and pain Abdomen. The clinical examination, Ultrasonography and
Magnetic resonance cholangiopancreatography (MRCP) and other relevant investigations
will help us to diagnose the disease earlier and relieve you of the disease by starting the
exact and early treatment.
If you are ready to participate in this research work, then you must sign a consent form and
you will be asked a few questions regarding the disease. You will be clinically examined and
after that we will perform Ultrasonography of the Abdomen and Magnetic resonance
cholangiopancreatography (MRCP). We assure that there is no risk involved. You will not
bear any extra expenditure for participating in this trial.
However, you are free to refuse the participation in this trial. You are also free to opt out of
the trial at any point of time and still you will get all the usual medical and surgical services
and nothing possible in the available infrastructure will be denied to you. All the information
provided by you will only be used for the study and the same will be kept confidential. Your
name and identity will not be disclosed anywhere.
Please feel free to ask any queries which may not have been answered by this material or
consent form itself.
Thank you.
র োগী তথ্য পত্র
ধ্নযিোদ.
रोगी सच
ू ना पत्र
रे डियो-निदाि विभाग, िीलरति सरकार मेडिकल कॉलेज एिं अस्पताल, कोलकाता में ,
आपका स्िागत है । हम जो शोध कर रहे हैं िह हैं "अल्ट्रासोिोग्राफी एंि मेगिेटिक रे जोिेंस
कोलािजजओप्यािक्रियोिोग्राफी (एमआरसीपी) के विभभन्ि प्रकार के कोलेिोकल भसस््स में
सहसंबंध"।
इस शोध कायय के माध्यम से हम विभभन्ि प्रकार के कोलेिोकल भसस््स की घििाओं की
सापेक्ष आिवृ ि का आकलि करिे जा रहे हैं और इस रोग में संिेदिशीलता और विभशष्िता
अल्ट्रासोिोग्राफी और मेगिेटिक अिुिादता कोलांगगयोपायरे रोग्राफी (एमआरसीपी) का
मूल्ट्यांकि करते हैं।
इस अध्ययि में आपको क्यों शाभमल क्रकया गया, यह है क्रक आप पीभलया / ऊपरी पेि के
द्रव्यमाि और ददय से पीड़ित हैं। जक्लनिकल परीक्षा, अल्ट्रासोिोग्राफी और मेगिेटिक रे जोिेंस
कोलािजजओप्यािक्रियोिोग्राफी (एमआरसीपी) और अन्य प्रासंगगक जांच से हमें पहले बीमारी का
पता लगािे और सिीक और प्रारं भभक उपचार शुरू करिे से बीमारी से मुक्त होिे में मदद
भमलेगी।
यटद आप इस शोध कायय में भाग लेिे के भलए तैयार हैं, तो आपको सहमनत फॉमय पर
हस्ताक्षर करिा होगा और आपको रोग के बारे में कुछ सिाल पूछे जाएंगे। आपको िैदानिक
रूप से जांच की जाएगी और इसके बाद हम अल्ट्रासोिोग्राफी और मेगिेटिक रे जोिेंस
कोलािजजओप्यािक्रियोिोग्राफी (एमआरसीपी)को क्रियाजन्ित करें गे। हम यह आश्िस्त करते हैं
क्रक इसमें कोई भी जोखिम िहीं है । इस परीक्षण में भाग लेिे के भलए आपको कोई
अनतररक्त िचय िहीं उठािा होगा।
हालांक्रक, आप इस परीक्षण में भागीदारी को अस्िीकार करिे के भलए स्ितंत्र हैं। आप क्रकसी
भी समय परीक्षण से बाहर निकलिे के भलए स्ितंत्र हैं और क्रफर भी आपको सभी सामान्य
गचक्रकत्सा और सजजयकल सेिाएं भमलें गी और उपलब्ध बुनियादी ढांचे में संभि कुछ भी आपको
अस्िीकार कर टदया जाएगा। आपके द्िारा प्रदाि की गई सभी जािकारी केिल अध्ययि के
भलए इस्तेमाल की जाएगी और इसे गोपिीय रिा जाएगा। आपका िाम और पहचाि कहीं भी
िल
ु ासा िहीं क्रकया जाएगा।
कृपया क्रकसी भी ऐसे प्रश्ि पछ
ू िे के भलए बेखििक महसस
ू करें जो इस सामग्री या सहमनत
से स्ियं का उिर िहीं टदया जा सकता है ।
धन्यिाद
CONSENT FORM
I,
Mr./Mrs. ---------------------------------------------------------------,
Address-----------------------------------------------------------------------------------,
am aware of the research work to be done by Dr. Jimut Bahan Murmu entitled
“Ultrasonography and Magnetic resonance cholangiopancreatography correlation in
different types of Choledochal Cysts” and do hereby declare that I am voluntarily giving my
consent to include myself as subject in the study.
I have been explained to my full satisfaction in my own language about the procedure
involved in the study along with the right to refuse to participate in the study at any time
during the course of the study. This refusal however is not going to interfere with the
treatment of my illness from the department.
I do hereby declare that I will provide medical history of the disease, undergo follow-up
clinical examination at regular interval for next two years, and allow collection of necessary
clinical material.
I also understand that this research study will help understand the disease better and
benefit the treatment of my illness. I have been assured that my medical records will be
kept confidential and will not be used without my permission. I have been assured that my
medical records will be kept confidential and will not be used without my permission.
I have also been informed to contact Dr. Jimut Bahan Murmu, MD PGT in the Dept. of Radio-
Diagnosis, Nilratan Sircar Medical College &Hospital in case of any emergency arising during
the study.
আডে,
শ্রী/শ্রীেতী
------------------------------------------------- -------------,
তোড খ্ :- ...........................
জোেগো:- ......................
सहमनतपत्र
मैं,
श्री/श्रीमती -------------------------------------------------- -------------,
ताररि :-
जगह :-
7.ADDITIONAL RESOURCES
The imaging modality used in my thesis is completely free of cost,so no financial disclosure
needed.
8.REFERENCES:
1) Todani T, Watanabe Y, Narusue M, Tabuchi K, Okajima K. Congenital bile duct
cysts: classification, operative procedures, and review of thirty-seven cases including
cancer arising from choledochal cyst. Am J Surg. 1977; 134:263–269.
2) Alonso-Lej F, Rever WB, Pessango DJ. Congenital choledochal cyst, with a report of
2, and analysis of 94 cases. Int Abstr Surg. 1959;108:1–30
3) Ziegler KM Ann Surg. 2010 Oct; 252(4):683-90. doi:
10.1097/SLA.0b013e3181f6931f
4) Liu CL, Fan ST, Lo CM, Lam CM, Poon RT, Wang J. Choledochal cysts in adults.
Arch Surg. 2002; 137:465–468.
5) Visser BC, Suh I, Way LW et-al. congenital choledochal cysts in adults. Arch Surg.
2004; 139 (8): 855-60.
6) Lilly JR, Stellin GP, Karrer FM. Forme fruste choledochal cyst. J Pediatr Surg.
1985;20:449–51
7) Todani T, Watanabe Y, Toki A, Morotomi Y. Classification of congenital biliary
cystic disease: special reference to type Ic and IVA cysts with primary ductal
stricture. J Hepatobiliary Pancreat Surg. 2003; 10:340–344.
8) Kaneyama K, Yamataka A, Kobayashi H, et al. Mixed type I and II choledochal cyst:
A new clinical subtype. Pediatr Surg Int. 2005;21:911–3
9) Lipsett PA -Choledochal cyst disease. A changing pattern Ann Surg. 1994 Nov;
220(5):644-52.
10) Kim OH, Chung HJ, Choi BG. Imaging of the choledochal cyst. Radiographics. 1995;
15 (1): 69-88.
11) Liu YB, Wang JW, Devkota KR, Ji ZL, Li JT, Wang XA, et al. Congenital choleochal
cysts in adults: twenty-five-year experience. Chin Med J. 2007;120:1404–1407.
12) Park DH, Kim MH, Lee SK, Lee SS, Choi JS, Lee YS, et al. Can MRCP replace the
diagnostic role of ERCP for patients with choledochal cysts? Gastrointest Endosc.
2005;62:360–366.
13) Loke TK, Lam SH, Chan CS. Choledochal cyst. An unusual type of cystic dilatation
of the cystic duct. AJR Am J Roentgenol. 1999;173:619–20.
14) Babbitt DP. Congenital choledochal cyst: New etiological concept based on
anomalous relationships of the common bile duct and pancreatic bulb. Ann Radiol
(Paris) 1969;12:231–40.
15) Huang SP, Wang HP, Chen JH, Wu MS, Shun CT, Lin JT. Clinical application of
EUS and peroral cholangioscopy in a choledochocele
with choledocholithiasis. Gastrointest Endosc. 1999;50:568–71
16) Komi N, Takehara H, Kunitomo K, Miyoshi Y, Yagi T. Does the type of anomalous
arrangement of pancreaticobiliary ducts influence the surgery and prognosis of
choledochal cyst? J Pediat Surg. 1992; 27:728–731.
CURRICULUM VITAE